1. Malvidin attenuates pain and inflammation in rats with osteoarthritis by suppressing NF-κB signaling pathway
    Teng Dai et al, 2017, Inflamm. Res. CrossRef
  2. Purinergic Signalling: Therapeutic Developments
    Geoffrey Burnstock, 2017, Front. Pharmacol. CrossRef
  3. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
    Geoffrey Burnstock et al, 2017, Purinergic Signalling CrossRef
  4. Sivelestat sodium hydrate improves post-traumatic knee osteoarthritis through nuclear factor-κB in a rat model
    Xiaofeng Yu et al, 2017 CrossRef
  5. The therapeutic potential of purinergic signalling
    Geoffrey Burnstock, 2018, Biochemical Pharmacology CrossRef
  6. P2X7, a critical regulator and potential target for bone and joint diseases
    Dehui Zeng et al, 2018, J Cell Physiol CrossRef
  7. P2X7 receptor deletion suppresses γ-radiation-induced hyposalivation
    Kristy E Gilman et al, 2019, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology CrossRef
  8. Extracellular ATP activates P2X7R-NF-κB (p65) pathway to promote the maturation of bone marrow-derived dendritic cells of mice
    Ying Yu et al, 2019, Cytokine CrossRef
  9. ADAM8 promotes chondrosarcoma cell migration and invasion by activating the NF-κB/MMP-13 signaling axis
    Yan Liu et al, 2019, Anti-Cancer Drugs CrossRef
  10. NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction.
    Moon-Chang Choi et al, 2019, Cells CrossRef
  11. Topical Application of Wogonin Provides a Novel Treatment of Knee Osteoarthritis
    Jacob F. Smith et al, 2020, Front. Physiol. CrossRef
  12. The Role of Inflammation in the Pathogenesis of Osteoarthritis
    Yoke Yue Chow et al, 2020, Mediators of Inflammation CrossRef
  13. Mechanism of aspirin-induced inhibition on the secondary hyperalgesia in osteoarthritis model rats
    Mizuho Niibori et al, 2020, Heliyon CrossRef
  14. Effect of autotaxin inhibition in a surgically-induced mouse model of osteoarthritis
    Poulami Datta et al, 2020, Osteoarthritis and Cartilage Open CrossRef
  15. Seomae mugwort and jaceosidin attenuate osteoarthritic cartilage damage by blocking IκB degradation in mice.
    Hyemi Lee et al, 2020, J Cell Mol Med CrossRef
  16. Purinergic System Signaling in Metainflammation-Associated Osteoarthritis
    Paula Gratal et al, 2020, Front. Med. CrossRef
  17. Platelet-Rich Plasma Combined with Alendronate Reduces Pain and Inflammation in Induced Osteoarthritis in Rats by Inhibiting the Nuclear Factor-Kappa B Signaling Pathway
    Feng Xin et al, 2020, BioMed Research International CrossRef
  18. P2X7 Receptor Induces Pyroptotic Inflammation and Cartilage Degradation in Osteoarthritis via NF-κB/NLRP3 Crosstalk
    Zihao Li et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  19. P2X7-induced nociception in the temporomandibular joint of rats depends on inflammatory mechanisms and C-fibres sensitization.
    Juliana M Teixeira et al, 2021, Eur J Pain CrossRef
  20. P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases
    Abtar Mishra et al, 2021, European Journal of Pharmacology CrossRef
  21. The role of P2X7 receptor in infection and metabolism: Based on inflammation and immunity
    Xiaoyu Cai et al, 2021, International Immunopharmacology CrossRef
  22. Role of Mitochondria in Physiology of Chondrocytes and Diseases of Osteoarthritis and Rheumatoid Arthritis
    Shiyi Kan et al, 2021, CARTILAGE CrossRef
  23. Initial effects of inflammation-related cytokines and signaling pathways on the pathogenesis of post-traumatic osteoarthritis
    Peng-Fei Han et al, 2018 CrossRef
  24. Relationship of mRNA Expression of Selected Genes in Peripheral Blood and Synovial Fluid in Cranial Cruciate Ligament Deficient Stifles of Dogs
    Karol Ševčík et al, 2022, Animals CrossRef
  25. P2X7 receptor in inflammation and pain
    Wen-jun Zhang, 2022, Brain Research Bulletin CrossRef
  26. Targeting inflammasome-dependent mechanisms as an emerging pharmacological approach for osteoarthritis therapy
    Sergio Ramirez-Perez et al, 2022, iScience CrossRef
  27. ATP ion channel P2X purinergic receptors in inflammation response
    Ji-peng Liu et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  28. Pannexin 3 activates P2X7 receptor to mediate inflammation and cartilage matrix degradation in temporomandibular joint osteoarthritis
    Jialing Xiao et al, 2023, Cell Biology International CrossRef
  29. Ion channels involved in inflammation and pain in osteoarthritis and related musculoskeletal disorders
    Csaba Matta et al, 2023, American Journal of Physiology-Cell Physiology CrossRef
  30. L-Carnitine augments probenecid anti-inflammatory effect in monoiodoacetate-induced knee osteoarthritis in rats: involvement of miRNA-373/P2X7/NLRP3/NF-κB milieu
    Rawan Mahfouz et al, 2023, Inflammopharmacol CrossRef
  31. Network pharmacology and molecular docking approach to investigate the mechanism of a Chinese herbal formulation Yougui pills against steroid-related osteonecrosis of the femoral head
    Ying Wang et al, 2024, Arabian Journal of Chemistry CrossRef
  32. α‐Solanine attenuates chondrocyte pyroptosis to improve osteoarthritis via suppressing NF‐κB pathway
    Jinyi Zhou et al, 2024, J Cellular Molecular Medi CrossRef
  33. P2X7 receptors: a bibliometric review from 2002 to 2023
    Haiting Tang et al, 2024, Purinergic Signalling CrossRef
  34. The impacts of obesity in rheumatoid arthritis and insights into therapeutic purinergic modulation
    Geórgia de Carvalho Braga et al, 2024, International Immunopharmacology CrossRef
  35. Ion channels in osteoarthritis: emerging roles and potential targets
    Renpeng Zhou et al, 2024, Nat Rev Rheumatol CrossRef
  36. Triptolide attenuates LPS-induced chondrocyte inflammation by inhibiting inflammasome activation via the Wnt/β-catenin and NF-κB signaling pathways
    Hangchu Shi et al, 2025, Cytotechnology CrossRef
  37. The P2X7-Mediated Mitochondrial ROS as an Emerging Core Target of Tuftsin Nanoparticles in Severe Acute Pancreatitis Therapy via Regulating Mitophagy
    E Wen et al, 2025, ACS Appl. Mater. Interfaces CrossRef